article thumbnail

Clearsynth receives government backing to advance India’s deuterated chemical production

Express Pharma

Source: [link] Deuterated compounds have vital uses in high-tech industries such as fiber optics, semiconductors, OLEDs, defence and pharmaceuticals. With TDB’s support, Clearsynth Labs aims to create a facility that will make India a supplier of high-value deuterated compounds.

article thumbnail

The EU AI Act: will regulation drive life science innovation away from Europe?

European Pharmaceutical Review

When the General Data Protection Regulation (GDPR) 1 came into effect in 2018, this appeared to accelerate the migration out of Europe for pharmaceutical clinical trials. This was not so much due to non-compliance but stemmed from regulatory ambiguity.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

C-suite shuffles ripple through pharma

PharmaVoice

Doustdar is now tasked with the challenge of navigating Novo’s new era as the second-place obesity leader, grappling with slower growth, potential incoming competitors and compounded versions of its drugs still available on the cheap for some patients.

article thumbnail

A Few Key Points Can Guide SGLT2 Inhibitor Management

Pharmacy Times

Janssen; 2018. Merck; 2017. Accessed June 20, 2025. Prescribing information. AstraZeneca; 2024. Accessed June 20, 2025. Prescribing information. Accessed June 20, 2025. Prescribing information. TheracosBio; 2023. Accessed June 20, 2025. Prescribing information. Boehringer Ingelheim; 2023.

article thumbnail

Hypertension: A Silent Killer Requiring Novel Therapies

Pharmacy Times

2018 ESC/ESH guidelines for the management of arterial hypertension. 2018; 39: 3021–3104. Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71:e127-e248. doi:10.1016/j.jacc.2017.11.006 2017.11.006 Williams B, Mancia G, Spiering W, et al. Eur Heart J.

article thumbnail

Insmed wins FDA approval for future blockbuster Brinsupri

Pharmaceutical Technology

Brinsupri joins the market alongside Insmed’s only other commercial therapy, Arikayce (amikacin), approved in 2018 to treat Mycobacterium avium complex (MAC) lung disease. GlobalData forecasts the bronchiectasis market to be worth $3.7bn in 2033 across the 8MM (US, France, Germany, Italy, Spain, UK, Japan, China).